Literature DB >> 21362320

Effects of hepatocyte growth factor-mediated activation of Dll4-Notch-Hey2 signaling pathway.

Yu-Fang Gao1, Xiao-Qin Ha, Tong-de Lü, Juan-Ping Han.   

Abstract

BACKGROUND: Hepatocyte growth factor (HGF) treats ischemic disease by promoting arteriogenesis, however, its mechanism of action is not known. The notch signaling pathway plays an important role in neovascularization. The relationship between the proliferation and migration ability of artery endothelial cells and the Dll4-Notch-Hey2 signaling pathway in the process of arteriogenesis was investigated as a mechanism of action of HGF.
METHODS: Based on the prophase study cells and supernatant were harvested at the indicated time after human femoral artery endothelial cells (HFAECs) were infected with adenovirus-HGF (Ad-HGF) at 200 pfu/cell. Cells were analyzed for HGF expression and Notch1, Dll4 and Hey2 expression by ELISA and reverse transcription-PCR (RT-PCR). The changes in the proliferation and migration ability of HFAECs were observed by MTT and Transwell migration experiments. Ad-GFP-infected HFAECs were used as control.
RESULTS: Compared with the control group the Ad-HGF group's HGF expression was not increased with time, and the induction by HGF of Notch1, Dll4 and Hey2 gene transcription was not enhanced with an increase of HGF. The proliferation ability of Ad-HGF-transduced HFAECs was enhanced and their migration ability was also enhanced in the presence of HGF.
CONCLUSIONS: Through activating the Dll4-Notch-Hey2 signaling pathway, HGF indirectly promotes the proliferation and migration ability of cells, so that offspring artery branches are formed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362320

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

1.  Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophages.

Authors:  Cansu Yıldırım; Daphne Y S Vogel; Maurits R Hollander; Josefien M Baggen; Ruud D Fontijn; Sylvia Nieuwenhuis; Anouk Haverkamp; Margreet R de Vries; Paul H A Quax; Juan J Garcia-Vallejo; Anja M van der Laan; Christine D Dijkstra; Tineke C T M van der Pouw Kraan; Niels van Royen; Anton J G Horrevoets
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

2.  HEY2, a target of miR-137, indicates poor outcomes and promotes cell proliferation and migration in hepatocellular carcinoma.

Authors:  Dan-Chun Wu; Mei-Fang Zhang; Shu-Guang Su; Heng-Ying Fang; Xue-Hua Wang; Dan He; Yuan-Yuan Xie; Xu-Hui Liu
Journal:  Oncotarget       Date:  2016-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.